Effects of ECM Ligands on RPE Reattachment to Bruch's
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 2001 - March 31, 2002
Grant ID
M2001018
Summary
The purpose of this study is to identify conditions that will increase the chance that transplanted RPE cells will attach to and subsequently grow on Bruch’s membrane in age-related macular degeneration patients. Dr. Del Priore is coating samples of a material that will help to stick the cells to the surface and thus increase the chances of cell survival. These experiments are being done using small pieces of Bruch’s membrane from eye bank donor eyes that have been affected by macular degeneration. Dr. Del Priore’s goal is to seed human RPE cells onto diseased human Bruch’s membranes and have them repopulate the membrane. He hopes to determine if coating the uppermost and deeper layers of diseased human Bruch’s membrane with sticky molecules will increase the initial attachment rate, growth rate and spreading rate of transplanted human RPE cells and promote the subsequent ability of these cells to repopulate this layer. He will then determine if coating these layers with a thin film of sticky material synthesized by the cells themselves (ECM, or “extracellular matrix”) will do the same thing. The long-term goal of these studies is to determine the ideal conditions for enhancing retinal pigment transplantation for the treatment of age-related macular degeneration. This project is a continuation of the previously funded study by the same name, which commenced in 1999.
Grantee institution at the time of this grant: University of Medicine and Dentistry of New Jersey
Related Grants
Macular Degeneration Research
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Neetu Kushwah, PhD
Current Organization
Boston Children’s Hospital
Macular Degeneration Research
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Krishna Singh, PhD
Current Organization
Johns Hopkins University School of Medicine
Macular Degeneration Research
The Development of a Transplant-Independent Therapy for RPE Dysfunction
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Shintaro Shirahama, MD, PhD
Current Organization
Schepens Eye Research Institute of Massachusetts Eye and Ear